Pharma World Congress held in India for the First time in 100 years     Prez Calls Upon Pharma Industry To Check Manufacture Of Spurious Drugs    FIP President inaugurates PSM INDIA stall at the world pharma congress exhibition     Two arrested for selling govt hospital's medicines    China tightens oversight of CMOs to curb counterfeiting    New Zealand drug formulary launched   DCGI office hands over cases relating to sale of banned drugs to respective State authorities for prosecution    Probe ordered into expired drugs supply by UK NGO   Health Ministers from 11 Asian countries commit to rational use of antibiotics   Centre to launch revised pharmacopoeia soon  Chinese pharma company's licence cancelled over inspection  

 

 

In this issue

PSM INDIA Founder , Mr.Bejon Misra addresses the FIP symposium on Counterfeit Medicines

National News

Global News

Drug Laws and Policy News

Pharma News

 

   
 

Centre to launch revised pharmacopoeia soon

HYDERABAD,7 SEP: The Union ministry of health and family welfare plans to launch a revised edition of National Formulary of India (NFI) soon, after a gap of 32 years. NFI is nothing but a database of medicines, their basic composition and the right dosages in which they should be taken. It is essentially meant for members of the medical profession and is an educational tool for medical students, nurses and pharmacists.

"For the first time, we will be launching an online version and even a common man can get to know details of the drugs prescribed by doctors. It will be an information centre for everyone," Dr B Suresh, chairman of the Indian Pharmacopoeia Commission ( IPC) told Express.

The last time NFI was revised was more than three decades ago. It was first published in 1960, again in 1966, and followed by a third edition in 1979 which covered 596 drugs. The latest version will include 431 more drugs and vaccines.

Importantly, the revised edition will have detailed information such as the ingredients, manufacturing standards, minimum and maximum dosages, drugtodrug interaction and adverse effects.

It covers 30 general chapters and 15 valueadded appendices including therapeutic drug monitoring, immunization schedule, National Health Programmes, Pharmacovigilance Programme of India besides others. Drugs used during pregnancy period have special focus. "The print version will be circulated to all hospitals, medical institutions, pharmacists across the country. We are also planning a mobile version, which should be ready shortly," Suresh said.

Source ; IBN Live

 
 

 

 

Valuable feedback to THE EDITOR - Pooja Khaitan, pooja@jagograhakjago.com

Pooja Khaitan - Editor

© 2011 Partnership for Safe Medicines India E-15/A, first floor, East of Kailash, New Delhi -110065 jagograhakjago.com; jagograhakjago.com; Consumer Conexion